Home
Amylyx Pharmaceuticals AMLX paid Tarplin, Downs & Young $80K for lobbying in Q4 2022 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q4 2022
- Client
- Amylyx Pharmaceuticals
- Reported
- 23/01/20
$80K on lobbying in 2022
What else happened in Amylyx Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 22/12/01~23/01/30Amylyx Pharmaceuticals's other lobbying reports
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 07/16
for Q2
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 04/20
for Q1
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 01/20
for Q4 2025
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 25/10/16
for Q3 2025
- Amylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
LobbyingAmylyx Pharmaceuticals
AMLX
$40K
$40K
Reported 25/07/16
for Q2 2025